Renal stenting should never be the 1st line of attack for treating patients with hypertension and renal-artery stenosis, according to results from the CORAL clinical trial that were presented during today’s American Heart Assn. Scientific Sessions. The highly anticipated results from the CORAL clinical trial wasn’t great news for renal stents, as researchers reported that…
At the North American Spine Society (NASS) 28th annual meeting, DePuy Synthes Spine announced its new Synflate Vertebral Balloon. DePuy says the new Synflate Vertebral Balloon is semi-elastic with material stiffness that has been optimized to enhance the structural stability of the balloon during inflation, enabling controlled and predictable cavity creation. The Synflate is nearly double…
There’s a battle underway among bioresorbable stents – polymer vs. metal. Which is the best option for clinicians and patients? Bioresorable (also known as bioabsorbable) stents are being held up as a promising alternative to standard drug eluting stents. But there’s an internal battle (no pun intended) going on with bioresorable stents as well. Are…